Alyve Health to enhance AI with $6M Series A funding
Alyve Health, an Indian startup offering personalised digital health plans for corporates, has raked a causa di $5.5 million a causa di a Series A funding round led by Axilor Ventures. The round was also participated by 1Crowd Fund, InHealth Ventures, and Trifecta Capital.
Founded a causa di 2020, the startup offers tailored comprehensive health plans, ranging from prevention to treatment, including 24/7 doctor consultations, diagnostics, medication, dental care, and gym memberships. It presently provides services to over a million members through its compagno insurers, brokers, financial institutions, clinics, diagnostic centres, and valore adattativo studios.
The startup will reportedly use its fresh funds to improve its patronato, security, and AI capabilities, as well as expand operations, hire more talent, and enhance services.
Huize begins Southeast Asia expansion with Vietnamese insurtech acquisition
Chinese insurance technology company Huize has acquired fellow insurtech company Global Care a causa di Vietnam.
The acquisition, it is said, marks the beginning of Huize’s international expansion, starting a causa di Southeast Asia, where markets parallel those of . Powered by AI and patronato analytics, Huize’s insurtech platform connects consumers, insurers, and insurance distributors. It provides a range of technology-enabled insurance solutions, including insurance consultation, customer engagement, marketing, risk management, and claims service.
Global Care, founded a causa di 2017, offers a range of cloud API solutions that assist insurers a causa di streamlining and digitising their sales processes, operations, and policy administration. Its portatile apps connect insurers with merchants and various distribution channels such as Grab and Ahamove, offering a wide selection of insurance products to a diverse basamento of customers.
Huize, through its global subsidiary Poni Insurtech, will buy a controlling stake a causa di Global Care, and later absorb it as one of its subsidiaries.
JLK bags first US FDA for AI solution
South Korean medical AI company JLK recently obtained regulatory approval a causa di the United States for its AI solution for prostate cancer diagnosis.
It received the 510(k) clearance for MEDIHUB Prostate, which uses AI to analyse prostate MRI scans and assess prostate-specific antigen levels. The AI software was developed through clinical trials with Seoul Asan Medical Center a causa di South Korea and the University of Missouri a causa di the US.
This is the first of five regulatory applications JLK has filed with the US FDA this year.
Online CBT relieves mental distress among Hong Kong uni students
A two-year study at a Hong Kong university has found an internet-based cognitive behavioural therapy (iCBT) programme effective a causa di alleviating mental health issues among students.
Researchers led by Dr Pan Jiayan, an associate professor of the Department of Social Work at Hong Kong Baptist University, tested the iCBT programme called REST Online to address growing mental health concerns of university students a causa di Hong Kong amid the shortage of professional support a causa di the city during the recent pandemic.
The 10-week self-guided programme involves eight online modules covering CBT skills briefing and debriefing, case demonstration videos, and online assignments and assessments. It also includes two counselling sessions with a therapist done a causa di person ora online.
Findings from the study, which have been published a causa di the academic journal Research Social Work Practice, showed a “significant” reduction of psychological distress, depressive and anxiety symptoms as well as negative thoughts and negative emotions, among student participants upon completion of the programme. There was also a noted increase a causa di their positive thoughts and emotions. The online sessions also showed “steady” improvement a causa di the participants’ mood.
